SENS PubMed Publication Search
Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
Nat Commun. 2020 Aug 27;11(1):4289. doi: 10.1038/s41467-020-18039-x.
Jasper Iske # 1 2, Midas Seyda # 1 2, Timm Heinbokel # 1 3, Ryoichi Maenosono # 1 4, Koichiro Minami 1 4, Yeqi Nian 1 5, Markus Quante 6, Christine S Falk 2, Haruhito Azuma 4, Friederike Martin 7, João F Passos 8 9, Claus U Niemann 10 11, Tamara Tchkonia 8, James L Kirkland 8, Abdallah Elkhal 1, Stefan G Tullius 12
Abstract:
...Here we show that cell-free mitochondrial DNA (cf-mt-DNA) released by senescent cells accumulates with aging and augments immunogenicity. Ischemia reperfusion injury induces a systemic increase of cf-mt-DNA that promotes dendritic cell-mediated, age-specific inflammatory responses. Comparable events are observed clinically, with the levels of cf-mt-DNA elevated in older deceased organ donors, and with the isolated cf-mt-DNA capable of activating human dendritic cells. In experimental models, treatment of old donor animals with senolytics clear senescent cells and diminish cf-mt-DNA release, thereby dampening age-specific immune responses and prolonging the survival of old cardiac allografts comparable to young donor organs. Collectively, we identify accumulating cf-mt-DNA as a key factor in inflamm-aging and present senolytics as a potential approach to improve transplant outcomes and availability.
PMID: 32855397
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453018/